<i>In vivo</i> evaluation of tropism and biodistribution of synthetic and natural adeno-associated viral vectors by next-generation sequencing
INTRODUCTION. The creation of synthetic adeno-associated virus (AAV) vectors during gene therapy development is a labour-intensive and expensive process. The optimal solution to minimise the time and costs associated with gene therapy development lies in the improvement of methods aimed at assessing...
Saved in:
Main Authors: | D. O. Maksimov, D. A. Naumova, E. A. Astakhova, V. V. Artemev, S. A. Biryukov, I. S. Abramov, A. A. Navoikova, N. V. Rudev, S. G. Feoktistova, O. V. Glazova, O. N. Mityaeva, P. Yu. Volchkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation. Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2024-07-01
|
Series: | Биопрепараты: Профилактика, диагностика, лечение |
Subjects: | |
Online Access: | https://www.biopreparations.ru/jour/article/view/582 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development of cell-based assay for detecting replication-competent adeno-associated virus by qPCR
by: Aishwarya Shevade, et al.
Published: (2025-09-01) -
Mass photometry as a robust method for characterizing adeno-associated virus critical quality attributes in gene therapy vector
by: Guangyu Wang, et al.
Published: (2025-09-01) -
Adeno-associated virus vector-based gene therapy for hereditary diseases: current problems of application and approaches to solve them
by: T. V. Egorova, et al.
Published: (2024-07-01) -
Artificial Intelligence‐Based Approaches for AAV Vector Engineering
by: Fangzhi Tan, et al.
Published: (2025-03-01) -
Astrocyte to neuron reprogramming with NeuroD1 for repair in canine stroke
by: Isaac H. Clark, et al.
Published: (2025-07-01)